glp 1 drugs semaglutide Diabetes advocacy group discourages use of compounded GLP-1 As GLP-1 Drug Shortage Ends,

Diabetic patients treated with semaglutide (Ozempic) showed dose-dependent weight loss with an average ~6 kg at a 2 mg dose with 40% of patients losing more than 10% of their weight (1)

These medications, with their transformative potential, have been around since 2005 for type 2 diabetes

The deeper reality is that GLP-1 medications reshape your microbiome, and the state of your microbiome determines how you experience those digestive changes

10.1007/s00125-014-3460-0 [DOI] [PubMed] [Google Scholar] 75.Vardarli I, Arndt E, Deacon CF, Holst JJ, Nauck MA

DPP-4 inhibition may influence glycemia by activating incretin receptors, preventing the release of bioactive peptides and affecting parasympathetic control of the digestive tract [29]

What GLP-1 medications for weight loss are there